                     AIDS Daily Summary 
                       March 30, 1995

The Centers for Disease Control and Prevention (CDC) National AIDS
Clearinghouse makes available the following information as a public
service only. Providing this information does not constitute endorsement
by the CDC, the CDC Clearinghouse, or any other organization. Reproduction
of this text is encouraged; however, copies may not be sold, and the CDC
Clearinghouse should be cited as the source of this information.
Copyright 1995, Information, Inc., Bethesda, MD


************************************************************
"Boy's Recovery From AIDS Virus Is Documented"
"Classes on AIDS Under Fire"
"Japan Court Rules HIV Patient Was Unlawfully Fired"
"Living Off AIDS"
"Catholic Church Making Strides on AIDS Attitude, Priest Says"
"German Fund to Help Victims of HIV-Tainted Blood"
"Home Testing Kits for HIV Apt to Get FDA Approval"
"Apoptosis in the Pathogenesis and Treatment of Disease"
"A Randomized Trial Comparing Fluconazole with Clotrimazole 
Troches for the Prevention of Fungal Infections in Patients with 
Advanced Human Immunodeficiency Virus Infection"
************************************************************

"Boy's Recovery From AIDS Virus Is Documented"
Washington Post (03/30/95) P. A12
     A Los Angeles child who was HIV-positive at birth appears to be 
free of the virus at age 5.  Yvonne J. Bryson of the medical 
school at the University of California at Los Angeles said she 
thought this was the first carefully documented case of someone 
conquering infection.  The findings were reported in Thursday's 
issue of the New England Journal of Medicine.  Bryson said she 
and her colleagues are studying the child's immune system, hoping
to find a way to stop infection in others.  Related Stories: New 
York Times (03/30) P. A18; Wall Street Journal (03/30) P. B8
      
"Classes on AIDS Under Fire"
Washington Times (03/30/95) P. A1;  Scarborough, Rowan
     At least two congressional panels plan to investigate the Clinton
administration's mandatory AIDS education for federal employees 
after hearing reports that the curriculum promotes the homosexual
lifestyle.  Rep. Robert K. Dornan (R-Calif.), chairman of the 
House National Security subcommittee on personnel, says he will 
hold hearings later this spring, and the House Government Reform 
and Oversight subcommittee on civil service has already begun a 
preliminary inquiry, according to a staffer.  House Speaker Newt 
Gingrich may look into the program after the conclusion of his 
"Contract with America," according to his spokesman, Tony 
Blankley.  The White House defended the program, which was 
directed to reach 2 million federal employees and is scheduled to
end in the coming days.  Richard Sorian, spokesman for the White 
House National AIDS Policy office, says that while he could not 
defend the conduct of every trainer, he believes the education 
will prove effective in preventing AIDS.  Conservative groups are
labeling the initiative as being "pro-gay."  Some federal workers
complained of being subjected to graphic talk about sex 
practices.  Concerned Women for America, a 600,000-member 
national organization, is urging Congress to investigate the 
program.  Grace Paranzino, a nurse with the U.S. Public Health 
Service who has conducted federal AIDS training sessions in 
Pennsylvania, admits some trainers do devote too much time to the
discussion of homosexual practices, but pointed out that "when we
talk about HIV and AIDS, it is a sexually transmitted disease, 
and therefore you cannot ignore it is sexually transmitted."
      
"Japan Court Rules HIV Patient Was Unlawfully Fired"
Reuters (03/30/95)
     The plaintiff in Japan's first court case challenging the 
dismissal of an employee who was fired for carrying HIV has been 
awarded more than $165,000 in damages by a Tokyo District Court. 
The plaintiff was fired in October 1992 by his employer, a 
Tokyo-based software company, after company officials 
administered an HIV test without the plaintiff's knowledge.  The 
company then disclosed the results of the test to other employees
in the office and to an affiliated firm.  In addition to ruling 
in favor of the plaintiff on the charges of wrongful dismissal, 
the court also ruled that the company had violated the man's 
privacy by releasing the test results and administering the test 
with his knowledge.  Japanese AIDS activists praised the 
decision, but warned that discriminatory practices against HIV 
patients remains a serious problem.
      
"Living Off AIDS"
Philadelphia Inquirer (03/30/95) P. A18
     The editors of the Philadelphia Inquirer say that people residing
in Philadelphia's AIDS-advocacy community are incensed over 
officials who take money earmarked to help those afflicted with 
the disease.  The editors say that the latest scandal of this 
kind revolves around Francis Stoffa, Jr., the former head of the 
Philadelphia AIDS Task Force, who has been charged by a grand 
jury with stealing more than $200,000 from the agency.  Although 
Stoffa denies doing anything wrong, the editors say his arrest 
"represents the worst sort of betrayal since he was described as 
a "hero and star" of the hard-hit gay community."  The editors 
point out that more troubling than the Stoffa scandal is "the 
fact that the whole system of distributing upwards of $20 million
in this region needs an overhaul," and blame mismanagement, 
political influence, and infighting as contributing to the 
system's problems.  Stoffa's arrest could be "a defining moment,"
the editors write," one in which [Philadelphia's] Rendell 
administration, AIDS-service providers, and advocates can foster 
change."  Two questions that should be raised, the editors 
believe, revolve around why the Philadelphia AIDS Consortium only
has 75 members, and why AIDS-service agencies don't keep some 
distance from funding decisions involving their organizations.  
The editors think that Health Commissioner Richman is the ideal 
person to raise these issues "and to ensure the vigilant 
monitoring of AIDS agency contracts." They conclude, "There isn't
the luxury of a long learning curve."
      
"Catholic Church Making Strides on AIDS Attitude, Priest Says"
St. Louis Post-Dispatch (03/29/95) P. 13A;  Volland, Victor
     The Catholic Church once denied the existence of AIDS and was 
even prejudiced against the condition, but the church has since 
made an impressive effort to overcome its initial attitude, 
observed Rev. Rodney J. DeMartini, the executive director of the 
National Catholic AIDS Network in San Francisco.  DeMartini was 
among about 75 other lay and religious ministers who recently 
attended a meeting concerning AIDS.  "We're building bridges 
rather than walls--within and outside the church," said 
DeMartini.  He added that society's denial of AIDS and its 
categorization of AIDS as a disease afflicting only homosexuals 
and drug addicts have delayed the actions needed to combat the 
disease.  Archbishop Justin Rigali, who attended one of the 
meeting's daily sessions, said that stereotypes of AIDS should be
abandoned.  He noted that women, the young, and the poor are most
at risk and recommended that all available resources be used to 
combat AIDS.
      
"German Fund to Help Victims of HIV-Tainted Blood"
Reuters (03/29/95)
     Germany's Health Minister, Horst Seehofer, said on Wednesday that
his country will make monthly payments to thousands of people who
contracted HIV in Germany's largest AIDS scandal.  The federal 
and state governments, the German Red Cross, and pharmaceutical 
companies plan to create a fund to help people made ill by 
tainted blood or blood products during the 1980s.  Seehofer told 
the German parliament's health committee that the federal 
government would contribute 100 million marks (US$72 million) to 
the fund, while the German Red Cross and pharmaceutical companies
together would contribute another 100 million marks.  Regional 
states will pay 50 million marks (US$36 million) into the fund, 
which will make monthly payments for 15 years to people infected 
before 1988 with HIV-contaminated blood.  Victims who contracted 
HIV will receive 1,500 marks (US$1,100), while people who develop
full-blown AIDS will receive twice that amount from the fund that
still must be created.  Victims and opposition parties 
immediately attacked the 250 million mark (US$180 million) fund, 
saying it was miserly.  The German Hemophiliac Association and 
the Hemophiliacs' Interest Group said the plan fell short of what
they expected or what was fair given the city of Bonn's admission
that most cases could have been prevented with proper blood 
screening.  Victims were either hemophiliacs whose long-term 
treatment was based on a blood product to prevent bleeding, or 
hospital patients given a similar medicine during operations.
      
"Home Testing Kits for HIV Apt to Get FDA Approval"
Journal of the American Medical Association (03/22/95-03/29/95) 
Vol. 273, No. 12, P. 908;  Marwick, Charles
     The Food and Drug Administration (FDA) has said it would approve 
home testing kits for detecting the presence of HIV as long as 
those who test positive are referred for counseling, and 
postmarketing studies are established to assess the public health
impact.  The FDA's change in position renews the debate of the 
value of home test kits for detecting HIV.  Some of the issues 
include whether the federal government can continue to keep 
people from using the new kits; whether it can require counseling
and enforce the gathering of data on the results of using the 
tests; and whether it can ensure anonymity, while at the same 
time making sure that counseling is provided for those who test 
HIV-positive.  At a Washington, D.C., forum to discuss the 
issues, some speakers expressed concern that when the home tests 
are approved, current testing systems would be seen as redundant.
A. Cornelius Baker, of the National Association of People with 
AIDS, noted that the test kits would be useful to people in 
isolated areas.  Baker was skeptical, however, about the value of
the kit as a weapon against AIDS.  The HIV home test kits have 
the support of the American Medical Association, as long as terms
similar to the FDA's proposal are adopted.
      
"Apoptosis in the Pathogenesis and Treatment of Disease"
Science (03/10/95) Vol. 267, No. 5203, P. 1456;  Thompson, Craig B. 
     Although a great deal is known about the control of cell 
proliferation, much less is known about the control of cell 
death.  Physiologic cell death occurs principally through a form 
of cell suicide called apoptosis.  A variety of regulatory 
stimuli cause a cell to undergo apoptosis.  Disorders associated 
with increased cell survival include cancer, autoimmune diseases,
and certain viral disorders.  Excessive cell death can result 
from acquired or genetic conditions that increase the 
accumulation of signals that induce apoptosis or that decrease 
the threshold at which such events cause apoptosis.  AIDS may be 
the most dramatic example of virus-associated cell depletion.  
Treatments created to specifically alter the apoptotic threshold 
may be able to change the natural progression of some of 
diseases.
      
"A Randomized Trial Comparing Fluconazole with Clotrimazole 
Troches for the Prevention of Fungal Infections in Patients with 
Advanced Human Immunodeficiency Virus Infection"
New England Journal of Medicine (03/16/95) Vol. 332, No. 11, P. 
700;  Powderly, William G.;  Finkelstein, Dianne M.;  Feinberg, 
Judith et al.
     Common complications in HIV-infected patients include 
cryptococcal meningitis and other serious fungal infections.  
Powderly et al. conducted a randomized trial comparing 
fluconazole, a drug effective for the long-term suppression of 
several fungal infections, with clotrimazole troches in patients 
who were also participating in a trial for the primary prevention
of Pneumocystis carinii pneumonia.  After about 35 months of 
follow-up, 4.1 percent of the patients in the fluconazole group 
and 10.9 percent of those in the clotrimazole group had developed
invasive fungal infections.  Seventeen of the 32 invasive fungal 
infections were cryptococcosis.  Fluconazole was more effective 
in the patients with 50 or fewer CD4 cells than for the patients 
with higher counts.  The drug was also effective in preventing 
esophageal candidiasis, and confirmed and presumed orapharyngeal 
candidiasis.  The researchers concluded that fluconazole taken 
prophylactically reduces the frequency of crytococcosis, 
esophageal candidiasis, and superficial fungal infections in 
patients infected with HIV, particularly those with 50 or fewer 
CD4 cells.  The drug, however, does not reduce overall mortality.
      
